Shanghai Huilun Jiangsu Pharmaceutical Co Ltd.

To evaluate the bioequivalence and safety of a single oral fasting and postprandial dose of homemade empagliflozin metformin extended-release tablets (5 mg/1000 mg) and empagliflozin metformin extended-release tablets (SYNJARDY® XR, 5 mg/1000 mg) produced by Boehringer Ingelheim Pharmaceuticals, Inc in healthy Chinese adult subjects.

To evaluate the bioequivalence and safety of a single oral administration of homemade dapoxetine hydrochloride tablets (60 mg) on an empty stomach or after a meal in healthy Chinese adult males and dapoxetine hydrochloride tablets (PRILIGY®, 60 mg, manufactured by Menarini-Von Heyden GmbH) produced by Berlin-Chemie AG.

Two trials were conducted to evaluate the efficacy and safety of azilsartan-amlodipine combination tablets in the treatment of essential hypertension that could not be effectively controlled by azilsartan tablets or amlodipine besylate tablets alone.